IP Library Granted Patent US 8,124,342
Granted Patent B2
US 8,124,342 · App. 12/786,033 · Granted Feb 28, 2012

Methods for nucleic acid manipulation

Assignee: The Pann State Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,124,342
App. No.
12/786,033
Granted
Feb 28, 2012
Kind
B2
Abstract

A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.

Claims (12)

1. A method of determining the presence of a target nucleic acid sequence in a sample comprising contacting said sample with a polymerase, bacteriophage T4 UvsX protein, and two primers that are complementary to the flanking ends of said target nucleic acid sequence; and detecting the presence of amplified target nucleic acid sequence.

2. The method of claim 1 , carried out at a constant temperature.

3. The method of claim 1 , carried out at a temperature below about 45° C.

4. The method of claim 1 , carried out in the presence of bacteriophage T4 UvsY protein.

5. The method of claim 1 , carried out in the presence of bacteriophage T4 gene product 32 protein.

6. The method of claim 1 , wherein said primers are present in a molar excess relative to said target nucleic acid sequence.

7. The method of claim 1 , carried out in the presence of a helicase.

8. The method of claim 7 , wherein said helicase is a bacteriophage T4 gene product 41 DNA helicase.

9. The method of claim 7 , wherein said helicase if bacteriophage T4 replicative helicase complex, comprising bacteriophage T4 gene product and gene product 59.

10. The method of claim 1 , carried out in the presence of nucleotide triphosphates in amounts sufficient to permit amplification of said target nucleic acid sequence.

11. The method of claim 1 , carried out at a temperature of about 37° C.

12. A method of determining the presence of a target nucleic acid sequence in a sample comprising contacting said sample with a polymerase, bacteriophage T4 UvsX protein, and two primers that are complementary to the flanking ends of said target nucleic acid sequence; and detecting the presence of amplified target nucleic acid sequence at a temperature of about 37° C.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2013
From: BENKOVIC, STEPHEN J; SALINAS, FRANK
To: THE PENN STATE RESEARCH FOUNDATION
Reel/Frame 030626/0906 →
CONFIRMATORY LICENSE Recorded Jun 28, 2010
From: PENNSYLVANIA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024600/0268 →
Continuity (4)
Continuation 11204125 · Aug 15, 2005
Continuation 10125973 · Apr 19, 2002
Provisional Application 60285127 · Apr 20, 2001
Related Publication 20100285481A1 · Nov 11, 2010